Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

SODIUM IODIDE I 123

SODIUM IODIDE I-123

Standard Dose
400uCi
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview SODIUM IODIDE I 123 is listed in Drugs@FDA under application 018671 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient SODIUM IODIDE I-123 Form and strength CAPSULE;ORAL - 400uCi Sponsor CARDINAL HEALTH 418 Submission history Latest submission status date: 2008-06-13 00:00:00.

Structured Monograph

Clinical summary

Approval overview SODIUM IODIDE I 123 is listed in Drugs@FDA under application 018671 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient SODIUM IODIDE I-123 Form and strength CAPSULE;ORAL - 400uCi Sponsor CARDINAL HEALTH 418 Submission history Latest submission status date: 2008-06-13 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.